mRNA |
PI-103 |
GDSC1000 |
pan-cancer |
AAC |
-0.0061 |
0.8 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0066 |
0.8 |
mRNA |
Irinotecan |
CCLE |
pan-cancer |
AAC |
0.01 |
0.8 |
mRNA |
Vandetanib |
CTRPv2 |
pan-cancer |
AAC |
-0.0071 |
0.8 |
mRNA |
5-FU |
CTRPv2 |
pan-cancer |
AAC |
0.0066 |
0.8 |
mRNA |
isoliquiritigenin |
CTRPv2 |
pan-cancer |
AAC |
-0.013 |
0.8 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0062 |
0.8 |
mRNA |
Bicalutamide |
GDSC1000 |
pan-cancer |
AAC |
0.0066 |
0.8 |
mRNA |
TW 37 |
GDSC1000 |
pan-cancer |
AAC |
-0.0065 |
0.8 |
mRNA |
Rapamycin |
gCSI |
pan-cancer |
AAC |
-0.01 |
0.8 |